Cat# : THP-0309
| Catalog# | Product Name | Availability | Size | Price | Qty |
|---|---|---|---|---|---|
| THP-0309 | Blisibimod, Recombinant Human BAFF/Tnfsf13b inhibitor | October 31, 2025 | 1 vial | $2,998.00 |
|
| Add to Cart Online Order Request a Bulk Order |
| Cat#: | THP-0309 |
| Product Name: | Blisibimod, Recombinant Human BAFF/Tnfsf13b inhibitor |
| Cas No: | 1236126-45-6 |
| Description: | Blisibimod is a novel selective inhibitor of B-cell activating factor (BAFF), binds to both cell membrane-expressed and soluble BAFF. |
| Sequences: | GCKWDLLIKQWVCDPLGSGSATGGSGSTASSGSGSATHMLPGCKWDLLIKQWVCDPLGGGGGVDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK |
| Species: | Human |
| Molecular Weight: | 63.58 kDa |
| Purity: | >95% by SDS-Page and HPLC analysis |
| Formula: | C2836H4376N756O858S26 |
| Endotoxin: | <0.1 EU per 1 μg of the peptide by the LAL method |
| Application: | Blisibimod has been used in trials studying the treatment of IgA Nephropathy, Microscopic Polyangiitis, Systemic Lupus Erythematosus, and Granulomatosis With Polyangiitis. |
For more information on how our products could help advance your project, please contact us.
ENTER YOUR EMAIL HERE TO SUBSCRIBE.
Copyright © 2025 Creative BioMart. All Rights Reserved.
